Number of shares and voting rights as at 31/10/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.
Read the press release (in French)
2026 Half-Year Results
- Revenue of €22.3 million, impacted by a reduction in production rates in the Industries segment;
- Half-year operating performance primarily impacted by the Industries division;
- Update on going concern and preferred strategic options.
Read the press release (in French)
Number of shares and voting rights as at 30/09/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th September.
Read the press release (in French)